Clinical trial

Dolutegravir Interactions With Artemisinin-based Combination Therapies

NCT02242799

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-06-01

PhasePHASE1

Study timeline

Study start (unknown)2015-06-01Date precision: month

Registry last updated2016-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malariaunresolved

HIVunresolved

Interventions

Dolutegravir 50mg odDRUG

Artemether-lumefantrine combinationDRUG

Artesunate-amodiaquineDRUG

Sponsors & collaborators

University of Liverpoollead sponsor

ViiV Healthcarecollaborator

Makerere Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02242799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.